The9 Limited announced that its Singapore-based investee, NYB, plans to go public through a business combination with RF Acquisition Corp II, valuing NYB at approximately $1.5 billion in pre-transaction equity. Under the proposed deal, NYB's existing shareholders, including The9, will roll over all their equity and retain a majority stake in the combined company, as well as designate most of its board of directors. The transaction has received approval from the boards of both NYB and RF Acquisition Corp II, with closing expected in the first or second quarter of 2026, subject to customary conditions. NYB, which recently won the top prize at the 2025 SuperAI Genesis Startup Competition, has partnered with Nvidia, HP, and Equinix to advance its AI-driven drug discovery efforts.